Showing results (101-110 of 370) with videos related to

Sort By:
Pageof 37
Scientific Reports|May 7, 2015
Reduced erythrocyte susceptibility and increased host clearance of young parasites slows Plasmodium growth in a murine model of severe malariaDavid S Khoury, Deborah Cromer, Shannon E Best, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|May 24, 2016
Infusion of solutions of pre-irradiated components in ratsGeorgina Pappas, Francoise Arnaud, Ashraful Haque, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2012
In vivo efficacy of a chimeric peptide derived from the conserved region of the M protein against group C and G streptococciTherese Nordström, Jessica Malcolm, Graham Magor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Plasmodium yoelii can ablate vaccine-induced long-term protection in miceMichelle N Wykes, Yong-Hong Zhou, Xue Q Liu, et al.
FEMS Immunology and Medical Microbiology|March 25, 2004
Immune response to superoxide dismutase in group A streptococcal infectionDavid J McMillan, Mark R Davies, Michael F Good, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Inhibition of 19-kDa C-terminal region of merozoite surface protein-1-specific antibody responses in neonatal pups by maternally derived 19-kDa C-terminal region of merozoite surface protein-1-specific antibodies but not whole parasite-specific antibodiesDanielle I Stanisic, Laura B Martin, Michelle L Gatton, et al.
Vaccines|July 26, 2020
Generation of a Peptide Vaccine Candidate against Falciparum Placental Malaria Based on a Discontinuous EpitopeCatherine J Mitran, Lauren M Higa, Michael F Good, et al.
Immunology and Cell Biology|April 10, 2002
Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technologyWendy A Hayman, Istvan Toth, Nicholas Flinn, et al.
The Journal of Infectious Diseases|October 17, 2006
A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteinsAshraful Haque, Karen Chu, Anna Easton, et al.
BMC Research Notes|March 1, 2017
Haemophagocytic syndrome in an adult suffering from pyrexia of unknown origin: an uncommon presentation of tuberculosis: a case reportWasim Md Mohosin Ul Haque, Md Erfanur Rahman Shuvo, Muhammad Abdur Rahim, et al.
Pageof 37